FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Zellers Jason 		2. Issuer Name and Ticker or Trading Symbol

ST JUDE MEDICAL INC [ STJ ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
VP, General Counsel & Corp Sec
(Last)          (First)          (Middle)

ONE ST. JUDE MEDICAL DRIVE 		3. Date of Earliest Transaction (MM/DD/YYYY)

10/31/2015
(Street)

ST. PAUL, MN 55117
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   10/31/2015     M    875   A   (1) 10349   (2) D    
Common Stock   10/31/2015     S    294   (3) D $64.66   10055   D    
Common Stock   11/2/2015     M    13333   A $34.96   23388   D    
Common Stock   11/2/2015     S    13333   D $64.29   (4) 10055   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units     (1) 10/31/2015     M         875    10/31/2012     (1) Common Stock   875   $0   0   D    
Stock Options (Right to Buy)   $34.96   11/2/2015     M         13333    12/17/2012   (5) 12/12/2019   Common Stock   26666   $0   13333   D    

Explanation of Responses:
( 1)  Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
( 2)  Includes 383 additional shares acquired through the Company Employee Stock Purchase Plan on 7/31/15.
( 3)  875 shares of restricted stock vested on October 31, 2015. 294 shares were used to pay taxes and 581 shares were released.
( 4)  The price in Column 4 is a weighted average. The prices actually received ranged from $64.15 to $64.49. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
( 5)  The option shares vest 25% on each of the first four anniversary dates of the date of the grant beginning on the date shown.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Zellers Jason
ONE ST. JUDE MEDICAL DRIVE
ST. PAUL, MN 55117

VP, General Counsel & Corp Sec

Signatures
/s/ Kashif Rashid, Attorney in Fact 11/4/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
SJM (NYSE:STJ)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more SJM Charts.
SJM (NYSE:STJ)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more SJM Charts.